ATXI logo

Avenue Therapeutics, Inc. Common Stock


ATXI: Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, an oral small molecule for CNS diseases, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.


Show ATXI Financials

Consumer Interest
SEC Filings

Recent trades of ATXI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ATXI's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ATXI in WallStreetBets Daily Discussion


Recent insights relating to ATXI

CNBC Recommendations

Recent picks made for ATXI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ATXI

Corporate Flights

Flights by private jets registered to ATXI